“I had treatment last year and I want to give something back.”
A trial looking at MRI scans during chemotherapy before surgery for breast cancer (Neo COMICE pilot trial)
This trial looked at having MRI scans during neoadjuvant chemotherapy for breast cancer. This trial was supported by Cancer Research UK.
Neoadjuvant chemotherapy usually takes 3 to 6 months. It doesn’t work for everyone, but doctors cannot find out if it is working until the end of chemotherapy.
We know from research that MRI scans may be able to show earlier on if treatment is helping. To find out for sure if MRI scans can help, researchers need to study a large number of people having this type of treatment. This will take a number of years. The research team wanted to see if this would be possible before doing a large and expensive trial, so they did this pilot study.
The aims were to
- Find out if it would be possible to do a much larger trial
- Get information that will shape the main trial
Summary of results
This pilot trial showed that it should be possible to do a larger trial looking at using MRI scans to see how well neoadjuvant treatment works for breast cancer.
This trial recruited 52 people from 13 hospitals in the UK. Everyone taking part was having chemotherapy before surgery for breast cancer (neoadjuvant treatment). They all had 4 scans during treatment.
Specially trained doctors called radiologists usually look at MRI scans to see where the area of cancer is. In this trial the scans were analysed by a computer as well, to see if this was as good as doing it in person. They used 2 different methods of computer analysis, and found that they appeared to work well and could be tested further in the larger trial.
The research team found that they were able to recruit people from different hospitals to take part in the trial quite easily. They felt there would be no problems recruiting enough people to do a larger trial.
The research team concluded that it should be possible to carry out a large scale trial testing the use of MRI scans during chemotherapy for breast cancer.
We have based this summary on information from the team who ran the trial. As far as we are aware, the information they sent us has not been reviewed independently (
How to join a clinical trial
Professor Lindsay Turnbull
Cancer Clinical Trials Unit Scotland (CaCTUS)
Cancer Research UK
Hull and East Yorkshire NHS Trust
National Institute for Health Research Cancer Research Network (NCRN)
University of Hull
This is Cancer Research UK trial number CRUK/08/018.